AbbVievsGlobus Medical

ABBV and GMED stock compared: price, dividend, valuation and results, from SEC filings.

GMED

Globus Medical, Inc.

$70.53

Value $9.5B

+0.77%
GMED's page

AbbVie (ABBV) has a market value of $506B and Globus Medical (GMED) $9.5B. Over the last year, with dividends, ABBV moved +25.9% and GMED -15.7%. The P/E is 49.1 for ABBV and 17.1 for GMED. Dividend yield: ABBV 2.42%, GMED none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$506B

    GMED$9.5B

    ABBV is 53 times GMED

  • Revenue, 12 months

    ABBV$66.0B

    GMED$3.1B

    ABBV is 21 times GMED

  • Net income, 12 months

    ABBV$10.3B

    GMED$558M

    ABBV is 19 times GMED

  • Operating margin

    ABBV32.2%

    GMED21.7%

    10.5 points apart

  • ROIC

    ABBV25.7%

    GMED11.7%

    14.0 points apart

  • P/E

    ABBV49.1

    GMED17.1

    ABBV is 2.9 times GMED

  • Dividend yield

    ABBV2.4%

    GMED0.0%

    2.4 points apart

  • 5-year return

    ABBV+191.4%

    GMED+0.0%

    191.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+191.4%

GMED+0.0%

10020030020222023202420252026
Returns by period
PeriodABBVWith dividendsGMEDWith dividends
1 year since November 17, 2025+25.9%Price +22.2%-15.7%Price -15.7%
3 years since November 17, 2023+128.7%+31.7% a yearPrice +106.8%+54.8%+15.7% a yearPrice +54.8%
5 years since November 17, 2021+191.4%+23.8% a yearPrice +143.7%+0.0%+0.0% a yearPrice +0.0%
10 years since November 18, 2016+610.5%+21.7% a yearPrice +372.6%+232.8%+12.8% a yearPrice +232.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieGMEDGlobus Medical

Valuation

ABBVGMED
Valuation
Price$286.01$70.53
Market value$506B$9.5B
Enterprise value (EV)$576B$9.0B
P/E49.117.1
P/E, 5-year median57.045.0
P/B–2.0
EV/EBIT27.113.3
Free cash flow yield3.7%8.0%

Results and growth

ABBVGMED
Results and growth
Revenue, 12 months$66.0B$3.1B
Net income, 12 months$10.3B$558M
Free cash flow, 12 months$18.9B$767M
Earnings per share, 12 months$5.81$4.06
Revenue growth, year on year8.6%16.7%
Revenue growth a year, past+5.9%over 5 years+30.1%over 5 years
EPS growth a year, past-2.8%over 5 years+31.2%over 5 years

Margins and returns on capital

ABBVGMED
Margins and returns on capital
Gross margin73.7%69.1%
Operating margin32.2%21.7%
Net margin15.7%17.8%
ROIC25.7%11.7%
ROE–12.0%

Balance sheet

ABBVGMED
Balance sheet
Cash$10.8B$517M
Total debt$80.9B$108M
Net debt / EBITDA3.2-0.5
Interest cover7.1×–

Dividends and buybacks

ABBVGMED
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$6.92–
Dividend growth a year, past+6.6%over 5 years–
Buyback yield0.2%3.2%
Shareholder yield2.6%3.2%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or GMED

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or Globus Medical?

By market value, AbbVie ($506B) is about 53.0 times Globus Medical ($9.5B), at today's prices.

How did ABBV and GMED stock do over the last 10 years?

Since November 18, 2016, ABBV's price moved +372.6% and GMED's +232.8%. With dividends: ABBV +610.5% (+21.7% a year), GMED +232.8% (+12.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or GMED?

The dividend yield at today's price is 2.42% for AbbVie and none for Globus Medical. Over the last twelve months they paid $6.92 and – per share.

What is the P/E of ABBV and GMED?

At today's price, the P/E is 49.1 for ABBV and 17.1 for GMED. The median of the last five years was 57.0 and 45.0, which shows where each stands against its own past.

Which has the higher profit margins, AbbVie or Globus Medical?

Over the last twelve months, the net margin was 15.7% for AbbVie and 17.8% for Globus Medical, and the operating margin 32.2% and 21.7%. Revenue was $66.0B and $3.1B.

Which is the better investment, AbbVie or Globus Medical?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.